Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diffusion-weighted MRI to Predict Treatment Response in Stereotactic Radiotherapy of CNS Metastases

NCT04700748 is registered in ClinicalTrials.gov with Lund University Hospital as lead sponsor.

NCT NCT04700748
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04700748 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diffusion-weighted MRI to Predict Treatment Response in Stereotactic Radiotherapy of CNS Metastases
Lead sponsor
Lund University Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 28, 2020
Completion date
May 26, 2026
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, radionecrosis, radiotherapy, sensitivity